Anal cancer screening – Authors’ reply - 29/06/12
Doi : 10.1016/S1470-2045(12)70272-3
Andrew E Grulich a 
, Dorothy A Machalek a, I Mary Poynten a, Fengyi Jin a, Christopher K Fairley b, c, Sepehr N Tabrizi d, e, f, g, Suzanne M Garland d, e, f, g, David J Templeton a, j, Richard J Hillman a, h, i
, Dorothy A Machalek a, I Mary Poynten a, Fengyi Jin a, Christopher K Fairley b, c, Sepehr N Tabrizi d, e, f, g, Suzanne M Garland d, e, f, g, David J Templeton a, j, Richard J Hillman a, h, i a The Kirby Institute for Infection and Immunity in Society, CFI Building, Corner West and Boundary Streets, Darlinghurst, NSW 2010, Australia
b Melbourne Sexual Health Centre, Carlton, VIC, Australia
c School of Population Health, University of Melbourne, VIC, Australia
d Department of Microbiology and Infectious Diseases, Royal Women’s Hospital, Parkville, VIC, Australia
e Department of Microbiology, Royal Children’s Hospital, Parkville, VIC, Australia
f Murdoch Children’s Research Institute, Parkville, VIC, Australia
g Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC, Australia
h Westmead Hospital, Sydney, NSW, Australia
i St Vincent’s Hospital, Sydney, NSW, Australia
j Sexual Health, Royal Prince Alfred Hospital, Sydney, NSW, Australia
Le texte complet de cet article est disponible en PDF.
© 2012
Elsevier Ltd. Tous droits réservés.
Vol 13 - N° 7
P. e280 - juillet 2012 Retour au numéro
Article précédent
- Anal cancer screening
- Joel Palefsky, John Michael Berry, Naomi Jay
- Focal HIFU for prostate cancer
- Barbara Alicja Jereczek-Fossa, Johannes H Kaanders, Bernard Dubray, Christopher Cottrill, Jan Willem Leer, on behalf of the Faculty of the Teaching Course on Evidence-Based Radiation Oncology of the European Society of Therapeutic Radiology and Oncology
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?